Menu
GeneBe

IMPDH2

inosine monophosphate dehydrogenase 2

Basic information

Region (hg38): 3:49024324-49029447

Links

ENSG00000178035NCBI:3615OMIM:146691HGNC:6053Uniprot:P12268AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
IMPDH2 enzyme activity, variation inADPharmacogenomicVariants may be involved in response to treatment with medications such as mycophenolate mofetil in individuals who have undergone transplantsBiochemical17496727

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IMPDH2 gene.

  • not provided (12 variants)
  • Inborn genetic diseases (8 variants)
  • Dystonic disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IMPDH2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
2
clinvar
15
clinvar
17
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 2 17 0 1

Variants in IMPDH2

This is a list of pathogenic ClinVar variants found in the IMPDH2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-49024514-C-T not specified Uncertain significance (Aug 14, 2023)2618265
3-49024547-C-G Uncertain significance (Jun 27, 2023)2505613
3-49024547-CAAACTT-C Uncertain significance (Sep 07, 2023)2758699
3-49024587-G-A IMPDH2-related disorder Likely benign (Sep 04, 2019)3052647
3-49024741-T-C not specified Uncertain significance (Sep 14, 2022)2311691
3-49025134-G-A Uncertain significance (Dec 01, 2022)2504438
3-49025182-C-T Uncertain significance (Apr 01, 2023)2653817
3-49025232-G-T Uncertain significance (Sep 24, 2022)2446351
3-49026365-C-T not specified Uncertain significance (Aug 04, 2023)2616119
3-49026549-A-G not specified Uncertain significance (Dec 28, 2023)3109570
3-49026677-A-G IMPDH2-related disorder Benign (Jan 21, 2021)1229935
3-49026719-G-A IMPDH2 enzyme activity, variation in Affects (Apr 01, 2007)14833
3-49026756-A-C not specified Uncertain significance (Oct 04, 2022)2383795
3-49026757-A-C Uncertain significance (Aug 11, 2022)1964147
3-49026791-C-G Uncertain significance (Jun 24, 2021)1329842
3-49026793-T-C Likely pathogenic (Feb 24, 2022)1966023
3-49026960-C-G Uncertain significance (May 15, 2019)1305966
3-49026965-T-C not specified Uncertain significance (Oct 12, 2022)2398827
3-49027038-T-C not specified Uncertain significance (Jun 03, 2022)2405114
3-49027052-G-A IMPDH2-related disorder Likely benign (Feb 14, 2020)3051076
3-49027801-G-A not specified Uncertain significance (Sep 29, 2023)3109569
3-49027859-G-A not specified Uncertain significance (Aug 02, 2021)2205912
3-49027873-G-C not specified Uncertain significance (Dec 19, 2022)2359650
3-49027903-C-T Dystonic disorder Likely pathogenic (Mar 17, 2021)1803982
3-49028438-G-T Uncertain significance (Mar 12, 2023)2581885

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IMPDH2protein_codingprotein_codingENST00000326739 145084
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000004360.9911256900581257480.000231
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.501762970.5920.00001733367
Missense in Polyphen46114.970.400111301
Synonymous-0.9311231111.110.000005971021
Loss of Function2.351325.90.5020.00000129307

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005170.000454
Ashkenazi Jewish0.0001030.0000992
East Asian0.0005490.000544
Finnish0.0001980.000185
European (Non-Finnish)0.0001500.000149
Middle Eastern0.0005490.000544
South Asian0.0003920.000392
Other0.0004890.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate- limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors.;
Pathway
Drug metabolism - other enzymes - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Mycophenolic acid Pathway, Pharmacokinetics;Mycophenolic acid Pathway, Pharmacokinetics/Pharmacodynamics;Mycophenolic Acid Metabolism Pathway;Neutrophil degranulation;Metabolism of nucleotides;urate biosynthesis/inosine 5,-phosphate degradation;purine nucleotides degradation;Innate Immune System;Immune System;Metabolism;Nucleobase biosynthesis;Purine nucleotides nucleosides metabolism;superpathway of purine nucleotide salvage;Purine ribonucleoside monophosphate biosynthesis;guanosine nucleotides <i>de novo</i> biosynthesis;guanosine ribonucleotides <i>de novo</i> biosynthesis;purine nucleotides <i>de novo</i> biosynthesis (Consensus)

Recessive Scores

pRec
0.394

Intolerance Scores

loftool
0.581
rvis_EVS
-0.65
rvis_percentile_EVS
16.36

Haploinsufficiency Scores

pHI
0.965
hipred
Y
hipred_score
0.701
ghis
0.610

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.975

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Impdh2
Phenotype
immune system phenotype; cellular phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
impdh2
Affected structure
whole organism
Phenotype tag
abnormal
Phenotype quality
decreased length

Gene ontology

Biological process
GMP biosynthetic process;GTP biosynthetic process;circadian rhythm;purine ribonucleoside monophosphate biosynthetic process;neutrophil degranulation;lymphocyte proliferation;protein homotetramerization;oxidation-reduction process;retina development in camera-type eye;cellular response to interleukin-4
Cellular component
extracellular region;nucleus;cytoplasm;peroxisomal membrane;cytosol;membrane;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen
Molecular function
nucleotide binding;DNA binding;RNA binding;IMP dehydrogenase activity;protein binding;metal ion binding